What are pre request to do medical management of ectopic pregnancy
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
I now have comprehensive information to provide a complete answer. Here is a detailed summary:
Prerequisites (Pre-requisites) for Medical Management of Ectopic Pregnancy
Medical management of ectopic pregnancy uses methotrexate (MTX), a folate antagonist that inhibits dihydrofolate reductase, preventing DNA synthesis in rapidly dividing trophoblastic tissue. Before initiating it, specific eligibility criteria must be confirmed and contraindications excluded.
✅ Inclusion Criteria (Patient Must Meet ALL of These)
| Criterion | Detail |
|---|---|
| Hemodynamically stable | No signs of rupture, internal bleeding, or cardiovascular compromise |
| No evidence of rupture | Confirmed by clinical exam and imaging |
| Unruptured ectopic pregnancy | Confirmed or highly suspected by TVUS ± β-hCG |
| Small ectopic mass | Gestational sac ≤ 3.5–4 cm in diameter |
| No fetal cardiac activity | Absence of embryonic cardiac motion on TVUS (relative contraindication if present) |
| Reliable follow-up possible | Patient can comply with serial β-hCG monitoring and return visits |
🔬 Pre-Treatment Investigations (Mandatory Before MTX)
Before administering methotrexate, the following baseline workup is required:
- Complete Blood Count (CBC) — rule out anemia, leukopenia, thrombocytopenia
- Liver Function Tests (LFTs) — must be normal (MTX is hepatotoxic)
- Renal Function (Creatinine/Electrolytes) — must be normal (MTX is renally cleared)
- Serum β-hCG (quantitative) — lower levels (< 5,000 mIU/mL) predict higher success; levels > 5,000 mIU/mL have a significantly higher failure rate (~14.3% vs. 3.7%)
- Blood type and Rh — for Rh immunoglobulin administration if Rh-negative
- Transvaginal Ultrasound (TVUS) — to confirm size, location, and absence of cardiac activity
- Chest X-ray — if any history of pulmonary disease (MTX can cause pneumonitis)
These studies are typically repeated 1 week after MTX to monitor for complications.
🚫 Absolute Contraindications (Must be ABSENT)
| Contraindication |
|---|
| Intrauterine pregnancy |
| Hemodynamic instability / ruptured ectopic |
| Breastfeeding |
| Hepatic dysfunction / active liver disease |
| Renal dysfunction / active renal disease |
| Active pulmonary disease |
| Hematologic disorders (moderate–severe anemia, leukopenia, thrombocytopenia) |
| Known sensitivity/allergy to methotrexate |
| Evidence of immunodeficiency |
| Poor patient compliance / inability to follow up |
⚠️ Relative Contraindications
| Relative Contraindication |
|---|
| Gestational sac > 4 cm |
| Embryonic cardiac activity seen on TVUS |
| β-hCG level > 5,000 mIU/mL (higher failure rate) |
📋 Summary in Simple Terms
The ideal candidate for medical management is a stable, non-breastfeeding patient with a small, unruptured ectopic pregnancy (< 4 cm, no cardiac motion), normal organ function (liver, kidneys, bone marrow), and the ability to attend follow-up for serial β-hCG monitoring.
Sources: Berek & Novak's Gynecology, p. 1771–1772 | Swanson's Family Medicine Review, p. 419 | Textbook of Family Medicine 9e, p. 493
This is a shared conversation. Sign in to Orris to start your own chat.